(Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | (Q1)Sep 30, 2022 | (FY)Jun 30, 2022 | (Q4)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -120.43%-257K | 330.41%1.81M | 49.83%-448K | -235.65%-1.43M | 52.10%-1.01M | -0.63%1.26M | -669.57%-786K | -151.09%-893K | -65.00%1.05M | -652.63%-2.1M |
Net income from continuing operations | 363.76%1.36M | 280.25%712K | 53.49%-934K | -424.03%-5.93M | -154.91%-3.01M | -279.79%-516K | -214.83%-395K | -245.61%-2.01M | 25.58%-1.13M | -194.03%-1.18M |
Operating gains losses | 245.83%35K | 88.46%-3K | 120.00%5K | 54.55%-85K | 96.68%-10K | -108.48%-24K | 88.02%-26K | -152.08%-25K | -3,840.00%-187K | -1,040.63%-301K |
Depreciation and amortization | -9.66%374K | -8.80%373K | -9.02%373K | 6.39%1.65M | 1.47%415K | 15.32%414K | 5.14%409K | 4.59%410K | 30.94%1.55M | 3.81%409K |
Asset impairment expenditure | ---413K | --135K | ---268K | 37,271.43%2.6M | --2.6M | --0 | --0 | --0 | -118.42%-7K | --0 |
Remuneration paid in stock | -69.57%7K | 42.42%47K | 65.49%-39K | -154.80%-97K | -122.73%-40K | 2,400.00%23K | 1,200.00%33K | -2,360.00%-113K | 1,280.00%177K | 5,966.67%176K |
Remuneration paid in stock | -36.67%38K | -50.75%33K | -48.68%39K | -17.24%264K | -50.81%61K | 3.45%60K | -27.17%67K | 68.89%76K | 11.15%319K | 96.83%124K |
Other non cashItems | -9.38%570K | -42.74%351K | -24.03%471K | 102.11%3.17M | 59.10%1.3M | 322.15%629K | 127.04%613K | 89.02%620K | 23.31%1.57M | 136.71%819K |
Change In working capital | -431.70%-2.23M | 110.96%163K | -164.63%-95K | -142.66%-2.99M | -8.34%-2.32M | 412.98%672K | -101.76%-1.49M | -90.32%147K | -170.10%-1.23M | -2,337.50%-2.15M |
-Change in receivables | -802.54%-1.66M | 207.07%1.11M | 273.54%1.41M | -116.42%-1.87M | 34.61%-1.45M | -14.18%236K | -814.16%-1.03M | -68.37%378K | -460.42%-865K | -902.17%-2.22M |
-Change in inventory | 141.43%875K | 183.42%1.02M | -363.09%-1.67M | -281.40%-2.93M | 79.32%-231K | -25.56%-2.11M | -450.72%-1.22M | -62.28%634K | 16.32%-769K | -75.08%-1.12M |
-Change in prepaid assets | -54.55%15K | -9.73%204K | 11.05%-338K | -114.84%-46K | -89.22%75K | -69.44%33K | 372.29%226K | 7.54%-380K | 181.15%310K | 551.95%696K |
-Change in payables and accrued expense | -119.98%-164K | -277.29%-1.2M | 134.63%276K | -210.88%-1.11M | -210.09%-818K | -47.17%821K | 51.53%-317K | -24.34%-797K | 20.43%1M | 0.95%743K |
-Change in other working capital | -176.56%-1.3M | -212.89%-972K | -28.53%223K | 426.02%2.97M | 142.04%103K | 1,466.13%1.69M | 464.83%861K | 201.96%312K | -145.82%-911K | 20.71%-245K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -120.43%-257K | 330.41%1.81M | 49.83%-448K | -235.65%-1.43M | 52.10%-1.01M | -0.63%1.26M | -669.57%-786K | -151.09%-893K | -65.00%1.05M | -652.63%-2.1M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 70.45%-78K | 97.96%-1K | -156.00%-64K | 88.26%-459K | 56.00%-121K | 73.33%-264K | 95.80%-49K | 98.31%-25K | -62.96%-3.91M | 86.51%-275K |
Net PPE purchase and sale | 70.45%-78K | 97.96%-1K | -156.00%-64K | 88.26%-459K | 56.00%-121K | 73.33%-264K | 95.80%-49K | 98.31%-25K | -62.96%-3.91M | 86.51%-275K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 70.45%-78K | 97.96%-1K | -156.00%-64K | 88.26%-459K | 56.00%-121K | 73.33%-264K | 95.80%-49K | 98.31%-25K | -62.96%-3.91M | 86.51%-275K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 61.92%-468K | -108.38%-163K | 7.35%555K | 46.19%1.48M | -89.99%246K | -101.81%-1.23M | 120.41%1.94M | 130.08%517K | -19.18%1.01M | 39.68%2.46M |
Net issuance payments of debt | 77.93%258K | 2,793.02%1.16M | -37.16%504K | 1,990.11%1.9M | 8.01%998K | 132.95%145K | -103.59%-43K | 150.44%802K | 727.27%91K | 560.00%924K |
Net common stock issuance | --0 | ---- | ---- | --896K | --0 | --0 | ---- | ---- | --0 | --0 |
Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Proceeds from stock option exercised by employees | --0 | --0 | --0 | 5,440.00%554K | --77K | --0 | --0 | --477K | -91.74%10K | --0 |
Interest paid (cash flow from financing activities) | -62.79%-713K | -128.66%-702K | -25.62%-353K | -40.16%-1.37M | 26.13%-342K | -144.69%-438K | -49.76%-307K | -117.83%-281K | -123.85%-976K | -261.72%-463K |
Net other financing activities | 98.61%-13K | -144.28%-619K | 183.99%404K | -126.83%-506K | -124.40%-487K | ---936K | --1.4M | ---481K | 1,711.97%1.89M | 4,439.13%2M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 61.92%-468K | -108.38%-163K | 7.35%555K | 46.19%1.48M | -89.99%246K | -101.81%-1.23M | 120.41%1.94M | 130.08%517K | -19.18%1.01M | 39.68%2.46M |
Net cash flow | ||||||||||
Beginning cash position | 50.42%1.77M | 69.44%122K | -82.64%83K | -79.74%478K | 126.00%956K | 55.00%1.18M | -92.08%72K | -79.74%478K | 363.46%2.36M | -81.54%423K |
Current changes in cash | -241.70%-803K | 48.51%1.65M | 110.72%43K | 77.92%-408K | -1,174.39%-881K | 29.43%-235K | 859.59%1.11M | 72.36%-401K | -199.52%-1.85M | -18.00%82K |
Effect of exchange rate changes | -146.15%-6K | 200.00%3K | 20.00%-4K | 139.39%13K | 129.63%8K | 425.00%13K | 0.00%-3K | -600.00%-5K | -371.43%-33K | 15.63%-27K |
End cash Position | 0.73%963K | 50.42%1.77M | 69.44%122K | -82.64%83K | -82.64%83K | 126.00%956K | 55.00%1.18M | -92.08%72K | -79.74%478K | -79.74%478K |
Free cash from | -134.10%-339K | 316.77%1.81M | 44.23%-512K | 37.32%-1.89M | 52.55%-1.13M | 260.14%994K | 29.12%-835K | -442.54%-918K | -599.00%-3.01M | -42.90%-2.38M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.